의료 영상용 AI 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 기술별, 용도별, 모달리티별, 최종 용도별, 지역별 및 경쟁(2021-2031년)

The global market for AI in medical imaging is projected to expand significantly, rising from USD 1.65 billion in 2025 to USD 4.35 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 17.54%. This sector utilizes machine learning and deep learning algorithms to analyze various diagnostic images, including X-rays, CT scans, and MRIs, with the aim of identifying diseases and quantifying physiological information. Key factors propelling this market growth include the increasing volume of imaging data, which necessitates automated solutions to alleviate radiologist burnout and enhance processing speed. Additionally, the demand for early disease detection and a shift towards value-based healthcare models are further encouraging the adoption of these technologies to boost diagnostic accuracy and operational efficiency.

However, the market's progress is hindered by challenges in smoothly integrating these AI tools into existing clinical workflows and electronic health record (EHR) systems, often resulting in isolated, non-interoperable solutions that slow down implementation. The rapid advancement in this field is underscored by regulatory trends; in 2024, approximately 80% of all medical AI algorithms cleared by the FDA were radiology applications, as reported by the American College of Radiology. While this high rate of clearance highlights the sector's swift development, it also emphasizes the substantial challenge of validating and effectively deploying these numerous models across diverse clinical settings.

Market Driver

A major driving force behind the adoption of artificial intelligence in diagnostic imaging is the severe shortage of radiologists and qualified imaging specialists. The growing gap between the increasing volume of medical images requiring interpretation and the limited available workforce is compelling healthcare providers to implement automated AI solutions. These solutions help prioritize urgent cases and reduce administrative workloads. The severity of this staffing issue is evident in systems like the United Kingdom, where the Royal College of Radiologists' June 2024 'Clinical Radiology Census 2023' projects a 30% deficit in clinical radiologists by 2028 if current recruitment and retention patterns continue. This makes AI an operational imperative for hospitals, crucial for maintaining care continuity and managing backlogs, rather than just a clinical enhancement.

Simultaneously, a significant rise in venture capital and government funding is accelerating the development of AI algorithms from conceptual stages to market-ready products. This financial backing enables developers to refine their deep learning models and navigate intricate regulatory processes, thereby expediting the market introduction of reliable tools. For instance, Rad AI's May 2024 'Series B Funding Announcement' revealed a $50 million investment to advance its generative AI for automating radiology reporting, illustrating this financial momentum. Such investments directly contribute to a greater availability of AI products, a trend highlighted by the U.S. Food and Drug Administration, which reported over 950 authorized AI and machine learning-enabled medical devices by 2024, showcasing the clear impact of capital on market supply.

Market Challenge

A significant obstacle for the global AI in medical imaging market is the difficulty of integrating AI tools into existing clinical workflows and electronic health record systems. While these algorithms offer diagnostic benefits, they frequently operate as isolated systems, lacking effective communication with Picture Archiving and Communication Systems (PACS). This fragmentation forces radiologists to switch between various applications to access AI-generated insights, introducing administrative inefficiencies that counteract the potential time savings from automation. As a result, clinicians experience increased cognitive burden and are often reluctant to adopt solutions that disrupt their established diagnostic processes.

This lack of interoperability directly hinders market growth by delaying widespread deployment across healthcare facilities. Providers are hesitant to invest in technologies that demand complex, customized setups or fail to seamlessly integrate results into patient records, which prolongs procurement timelines. A 2024 report by the European Society of Radiology indicated that 24% of radiology professionals consider IT and systems integration as a primary barrier to AI implementation in clinical practice. Without straightforward, "plug-and-play" compatibility, AI innovations struggle to move beyond initial pilot phases to become scalable, revenue-generating operations, thereby restricting the sector's overall growth potential.

Market Trends

The market is undergoing a significant transformation with the adoption of generative AI for synthetic data generation and image reconstruction, addressing issues like data scarcity and improving scan quality. Unlike conventional diagnostic algorithms that depend on extensive labeled datasets, generative models are now used to produce high-fidelity synthetic images for training, which helps to alleviate privacy concerns and reduce dataset bias. Moreover, this technology is transforming image reconstruction, allowing for the creation of diagnostic-grade scans from lower-dose inputs, thereby substantially decreasing patient radiation exposure and speeding up MRI acquisition. This strategic pivot towards generative AI is clearly reflected in its swift industry adoption; a March 2025 NVIDIA report, 'State of AI in Healthcare and Life Sciences: 2025 Trends', stated that 54% of healthcare organizations are actively utilizing generative AI workloads, signaling a move beyond purely analytical models towards innovative data solutions.

Concurrently, the expansion of AI-driven workflow automation and triage solutions is emerging as a vital response to the operational overload faced by radiology departments. These systems are now taking on broader roles beyond just pixel-level diagnosis, increasingly managing the entire radiology process, from automated protocol selection to intelligently prioritizing critical cases in worklists. This trend emphasizes reducing cognitive burden and administrative burnout, ensuring that urgent pathologies are immediately highlighted for radiologist attention, rather than solely focusing on diagnostic sensitivity. The widespread acknowledgment of this operational necessity is underscored by a January 2025 study in the Journal of the American College of Radiology, 'Artificial Intelligence in Radiology: A Leadership Survey', where 100% of academic radiology chairs surveyed indicated plans to implement AI specifically to enhance departmental quality and operational efficiency.

Key Market Players

• Digital Diagnostics Inc.
• Tempus AI, Inc.
• Advanced Micro Devices, Inc.
• HeartFlow, Inc.
• Enlitic, Inc.
• Viz.ai, Inc.
• EchoNous Inc.
• HeartVista Inc.
• Exo Imaging, Inc.
• Nano-X Imaging Ltd.

Report Scope

In this report, the Global AI In Medical Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

AI In Medical Imaging Market, By Technology

• Deep Learning
• Natural Language Processing
• Others

AI In Medical Imaging Market, By Application

• Neurology
• Respiratory & Pulmonary
• Cardiology
• Breast Screening
• Orthopedics
• Others

AI In Medical Imaging Market, By Modalities

• CT scan
• MRI
• X-rays
• Ultrasound
• Nuclear Imaging

AI In Medical Imaging Market, By End Use

• Hospitals
• Diagnostic Imaging Centers
• Others

AI In Medical Imaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global AI In Medical Imaging Market.

Available Customizations:

Global AI In Medical Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global AI In Medical Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Deep Learning, Natural Language Processing, Others)
  • 5.2.2. By Application (Neurology, Respiratory & Pulmonary, Cardiology, Breast Screening, Orthopedics, Others)
  • 5.2.3. By Modalities (CT scan, MRI, X-rays, Ultrasound, Nuclear Imaging)
  • 5.2.4. By End Use (Hospitals, Diagnostic Imaging Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America AI In Medical Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Application
  • 6.2.3. By Modalities
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States AI In Medical Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Modalities
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada AI In Medical Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Modalities
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico AI In Medical Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Modalities
      • 6.3.3.2.4. By End Use

7. Europe AI In Medical Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Application
  • 7.2.3. By Modalities
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany AI In Medical Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Modalities
      • 7.3.1.2.4. By End Use
  • 7.3.2. France AI In Medical Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Modalities
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom AI In Medical Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Modalities
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy AI In Medical Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Modalities
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain AI In Medical Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Modalities
      • 7.3.5.2.4. By End Use

8. Asia Pacific AI In Medical Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Application
  • 8.2.3. By Modalities
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China AI In Medical Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Modalities
      • 8.3.1.2.4. By End Use
  • 8.3.2. India AI In Medical Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Modalities
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan AI In Medical Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Modalities
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea AI In Medical Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Modalities
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia AI In Medical Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Modalities
      • 8.3.5.2.4. By End Use

9. Middle East & Africa AI In Medical Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Application
  • 9.2.3. By Modalities
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia AI In Medical Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Modalities
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE AI In Medical Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Modalities
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa AI In Medical Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Modalities
      • 9.3.3.2.4. By End Use

10. South America AI In Medical Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Application
  • 10.2.3. By Modalities
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil AI In Medical Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Modalities
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia AI In Medical Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Modalities
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina AI In Medical Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Modalities
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global AI In Medical Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Digital Diagnostics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Tempus AI, Inc.
• 15.3. Advanced Micro Devices, Inc.
• 15.4. HeartFlow, Inc.
• 15.5. Enlitic, Inc.
• 15.6. Viz.ai, Inc.
• 15.7. EchoNous Inc.
• 15.8. HeartVista Inc.
• 15.9. Exo Imaging, Inc.
• 15.10. Nano-X Imaging Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer